Dear all,

I surely was not hoping in such a huge response to my original question.
I think we all have read excellent contributions, and pleasant posts.
Although, as often happens, a unique consensus has not emerged, I have for sure 
a clearer idea of what I should use in the future, and have learnt a few 
interesting things.
Thank you all for that.
It's maybe time to step forward from this thread.
Thank you all, once again,
ciao,
s


-- 
Sebastiano Pasqualato, PhD
Crystallography Unit
Department of Experimental Oncology
European Institute of Oncology
IFOM-IEO Campus
via Adamello, 16
20139 - Milano
Italy

tel +39 02 9437 5167
fax +39 02 9437 5990

please note the change in email address!
sebastiano.pasqual...@ieo.eu







Reply via email to